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Abstract 18 
Schistosoma mansoni, like other trematodes, expresses a number of unusual calcium binding 19 
proteins which consist of an EF-hand domain joined to a dynein light chain-like (DLC-like) domain by 20 
a flexible linker.  These proteins have been implicated in host immune responses and drug binding.  21 
Three members of this protein family from S. mansoni (SmTAL1, SmTAL2 and SmTAL3) have been 22 
well characterised biochemically.  Here we characterise the remaining family members from this 23 
species (SmTAL4-13).  All of these proteins form homodimers and all except SmTAL5 bind to calcium 24 
and manganese ions.  SmTAL9, 10 and 11 also bind to magnesium ions.  The antischistosomal drug, 25 
praziquantel interacts with SmTAL4, 5 and 8.  Some family members also bind to calmodulin 26 
antagonists such as chlorpromazine and trifluoperazine.  Molecular modelling suggests that all ten 27 
proteins adopt similar overall folds with the EF-hand and DLC-like domains folding discretely.  28 
Bioinformatics analyses suggest that the proteins may fall into two main categories:  (i) those which 29 
bind calcium ions reversibly at the second EF-hand and may play a role in signalling (SmTAL1, 2, 8 30 
and 12) and (ii) those which bind calcium ions at the first EF-hand and may play either signalling or 31 
structural roles (SmTAL7, 9, 10 and 13).  The remaining proteins include those which do not bind 32 
calcium ions (SmTAL3 and 5) and three other proteins (SmTAL4, 6 and 11).  The roles of these 33 
proteins are less clear, but they may also have structural roles. 34 
 35 
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Introduction 40 
Schistosoma mansoni and related blood flukes from the same genus cause a substantial burden of 41 
disease on humanity.  It is estimated that 207 million people are infected by S. mansoni and every 42 
year it accounts for up to 280,000 deaths, second only to malaria among parasitic diseases [1-3].  43 
The infection can be treated by the drug praziquantel [4].  This is generally well tolerated and 44 
effective [5, 6].  In the absence of a vaccine, mass drug administration projects are using 45 
praziquantel to break the cycle of infection in large populations [7, 8].  Interestingly, despite 46 
widespread use of the drug, reports of resistance to it are rare [6, 9].  However, bone fide resistance 47 
has been generated in the laboratory and it is assumed that it will eventually emerge in clinically 48 
relevant populations of the parasite [10].  Praziquantel’s molecular target and mechanism of action 49 
are unknown [6, 11-13].  However, it is well-established that one of its effects is to disrupt calcium 50 
ion homeostasis resulting in uncontrolled influx of the ion and subsequent paralysis of the organism 51 
[4].  Therefore, calcium-regulatory systems in S. mansoni are of interest since they may provide clues 52 
about praziquantel’s mode of action or identify potential novel targets which could be antagonised 53 
by new anti-schistosomal drugs. 54 
In trematodes, there is a family of unusual calcium binding proteins which consist of an N-terminal 55 
EF-hand containing domain and a C-terminal dynein light chain-like (DLC-like) domain [14, 15].  56 
Typically, trematodes have multiple isoforms of these proteins and their functions are not known.  In 57 
S. mansoni there are 13 known members of the tegumental allergen (TAL) family of proteins, 58 
referred to as SmTAL1 etc [16].  These proteins have been linked to IgE-mediated immune responses 59 
in the host [17-19].  Partial protection from infection resulted from immunisation of mice with 60 
SmTAL1 [20].  Immunisation of mice with the Schistosoma japonicum protein SjTP22.4 (equivalent to 61 
SmTAL11) was synergistic with PZQ in killing the worm [21].  One family member (SmTAL3) has been 62 
identified as part of a complex which also includes a component of the microbule motor, dynein 63 
[22].  In the liver flukes Fasciola hepatica and Facsiola gigantica four members of the family have 64 
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been identified and characterised [23-30].  It seems likely that further family members will be 65 
revealed in these species once their genomes are fully annotated.  The four family members from F. 66 
hepatica characterised so far differ in their ion and drug binding properties, but all are predicted to 67 
have similar structures and all are able to dimerise.  Family members have also been identified in the 68 
Chinese liver fluke Clonorchis sinensis and the carcinogenic liver fluke Opisthorchis viverrini [31-33]. 69 
As likely calcium-signalling proteins which appear to be unique to helminths, these proteins are of 70 
interest as potential drug targets.  They are also of fundamental interest given that no similar 71 
proteins have been reported in other taxa.  Although the protein family has high levels of sequence 72 
and predicted structural similarity, substantial variation in their biochemical properties has been 73 
observed.  For example, while the majority of family members bind to calcium ions, some (e.g. 74 
SmTAL3) do not [34, 35].  However, the in vivo roles for the proteins and the need for large numbers 75 
of family members in each species remain largely unclear. 76 
We have previously characterised the biochemical properties of SmTAL1 (Smp_045200.1; Sm22.6), 77 
SmTAL2 (Smp_086480.1; Sm21.7) and SmTAL3 (Smp_086530.1; Sm20.8) [34].  Here, we extend that 78 
work by reporting the characterisation of the remaining, known SmTAL proteins, namely:  SmTAL4 79 
(Smp_169190.1), SmTAL5 (Smp_195090.1), SmTAL6 (Smp_072620.1), SmTAL7 (Smp_042140.1), 80 
SmTAL8 (Smp_086470.1; Sm21.6), SmTAL9 (Smp_077310.1) SmTAL10 (Smp_074460.1), SmTAL11 81 
(Smp_169200.1), SmTAL12 (Smp_045010.1) and SmTAL13 (Smp_042150.1).  We investigated their 82 
ion binding properties, calmodulin antagonist interactions, oligomerisation properties and predicted 83 
three-dimensional structures.  Based on these data, and associated bioinformatics analyses, we 84 
propose some functional classifications for this group of proteins. 85 
 86 
Materials and Methods 87 
Bioinformatics and molecular modelling 88 
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SmTAL proteins were modelled using Phyre2 in the intensive mode [36, 37].  These initial models 89 
were energy minimised using YASARA [38].  Where our analyses suggested that the proteins bound 90 
calcium ions at the second EF-hand (SmTAL8 and SmTAL12; see Results), the models were aligned to 91 
the EF-hand from Reps1 (PDB:  1FI6 [39]) which was a highly ranked template for the majority of the 92 
models and contained a bound calcium ion.  Where our analyses suggested that the first EF-hand 93 
binds calcium ions (SmTAL7, 9, 10 and 13; see Results), the models were aligned to human CaBP7 94 
(PDB:  2LV7 [40]), another highly ranked template.  A new structure was generated by saving the 95 
SmTAL protein together with the calcium ion in the appropriate EF-hand and then this structure was 96 
minimised using YASARA.  The final, minimised models are provided as supplementary information 97 
to this paper.  Ramachadran plots were calculated using RAMPAGE 98 
(http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) [41]. 99 
To investigate relationships between SmTAL proteins we constructed phylogenetic trees based on 100 
Kraemer et al’s analysis of S100 proteins [42].  Multiple sequence alignments were performed in 101 
MEGA, version 6.06 [43, 44], using MUSCLE with the default parameters [45, 46]. Trees were 102 
optimised for maximum likelihood analysis, and the substitution method with the lowest Bayesian 103 
information criterion (BIC) score was chosen for the final tree.  Neighbour-joining analyses were also 104 
carried out using MEGA.  In both cases, evolutionary distances were estimated using the JTT method 105 
[47].  Both trees were tested with 1000 bootstrap replications [48], and rooted using several 106 
representatives of another EF-hand protein, calmodulin (CaM) as an outgroup. 107 
 108 
Expression and purification of SmTAL proteins 109 
DNA sequences coding for SmTAL4-SmTAL13 were amplified by PCR.  SmTAL4, 5 and 8 coding 110 
sequences were amplified from plasmids kindly provided by Dr Colin Fitzsimmons (University of 111 
Cambridge, UK) [16].  The remaining coding sequences were amplified from S. mansoni cDNA 112 
provided by the Schistosomiasis Resource Center for distribution by BEI Resources, NIAID, NIH 113 
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(Manassas, VA, USA; https://www.beiresources.org/) [49].  SmTAL7, 8 10 and 12 coding sequences 114 
were amplified from adult S. mansoni cDNA (Strain PR-1, NR-48633, Lot 62506671), SmTAL6 and 9 115 
from miracidia cDNA (Strain PR-1, NR-48631, Lot 62506669) and SmTAL13 from cercariae cDNA 116 
(Strain PR-1, NR-48632, Lot 62506670).  Primers were designed to facilitate insertion of the 117 
amplicons into pET43 Ek/LIC (Merck, Nottingham, UK) using ligation independent cloning and 118 
following the manufacturer's protocol.  This vector introduces bases coding for the amino acid 119 
sequence MAHHHHHHVDDDDK at the 5’-end of the amplicon facilitating the purification of the 120 
recombinant protein by metal ion affinity chromatography.  Correct insertion of the amplicons was 121 
checked by PCR and sequencing of the complete gene sequences (GATC Biotech, London, UK). 122 
All SmTAL proteins were expressed in, and purified from, Escherichia coli.  SmTAL5 and SmTAL9 were 123 
expressed in E. coli Rosetta(DE3) (Merck, Nottingham, UK) and the remaining SmTAL proteins in E. 124 
coli HMS174(DE3) (Merck).  Single, recombinant colonies containing expression vectors for SmTAL4 125 
and SmTAL6 were picked and cultured overnight, shaking at 37 °C in 5 ml of LB (Miller) broth 126 
supplemented with 100 µgml-1 ampicillin.  This culture was diluted into 1 l of LB(Miller) broth 127 
supplemented with 100 µgml-1 ampicillin and grown, shaking at 37 °C for 3-4 h.  After this time 128 
protein expression was induced by the addition of 0.3 g IPTG and the culture was grown, shaking at 129 
37 °C for a further 4-5 h.  SmTAL7, SmTAL8, SmTAL10, SmTAL11, SmTAL12 and SmTAL13 were 130 
expressed using the same protocol except that 0.4 g IPTG was used to induce expression.  For 131 
SmTAL5, a recombinant colony was picked and cultured in 5 ml LB (Miller) supplemented with 100 132 
µgml-1 ampicillin and 34 µgml-1 chloramphenicol overnight shaking at 30 °C.  This culture was diluted 133 
into 1 l of LB (Miller) supplemented with 100 µgml-1 ampicillin and 34 µgml-1 chloramphenicol and 134 
grown shaking at 30 °C for 8-9 h before induction with 0.3 g IPTG.  The temperature of the culture 135 
was reduced to 16 °C and the cells grown overnight.  For SmTAL9, a single recombinant colony was 136 
cultured in 5 ml LB (Miller) supplemented with 100 µgml-1 ampicillin and 34 µgml-1 chloramphenicol 137 
for 9 h shaking at 37 °C.  This culture was diluted into 100 ml LB(Miller) supplemented with 100 138 
µgml-1 ampicillin and 34 µgml-1 chloramphenicol and grown overnight shaking at 37 °C before being 139 
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diluted into 1 l of LB(Miller) supplemented with 100 µgml-1 ampicillin and 34 µgml-1 chloramphenicol 140 
and grown for a further 9 h shaking at 37 °C.  Protein expression was then induced by the addition of 141 
0.25 g IPTG, the temperature of the culture was reduced to 16 °C and the cells grown overnight.  In 142 
all cases, cells were harvested by centrifugation at 4200 g for 20 min.  Cell pellets were resuspended 143 
in approximately 25 ml buffer R (50 mM Hepes-OH, pH 7.5, 150 mM NaCl, 10% (v/v) glycerol) and 144 
frozen at -80 °C until required. 145 
All the SmTAL proteins were purified by cobalt affinity chromatography essentially as previously 146 
described [29].  Briefly, cells were thawed, disrupted by sonication and the suspension clarified by 147 
centrifugation (22,000 g for 20 min).  The cell extract was passed over a 1 ml cobalt agarose column 148 
(His-Select, Sigma, Poole, UK), which had been equilibrated in buffer W (buffer R, except 500 mM 149 
NaCl).  The column was washed in 20 ml of buffer A and SmTAL proteins eluted with two 2 ml 150 
aliquots of buffer E (buffer A supplemented with 250 mM imidazole).  Protein containing fractions 151 
were identified and dialysed overnight at 4 °C against buffer D (buffer R supplemented with 1 mM 152 
DTT).  Purified proteins were frozen in aliquots of 20-100 µl at -80 °C until required.  Once thawed, 153 
proteins were not refrozen. 154 
 155 
Native gel electrophoresis 156 
SmTAL4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 were resolved by discontinuous gel electrophoresis under 157 
non-denaturing conditions to detect ion binding.  Proteins (SmTAL4, 52 µM; SmTAL5 and 10, 15 µM; 158 
SmTAL6 60 µM; SmTAL8, 40 µM; SmTAL12 and 13, 20 µM; all others 10 µM) were incubated at 37 °C 159 
for 30 min in the presence of either 2 mM EGTA or 2 mM EGTA/4 mM divalent cation in a total 160 
volume of 10 µl.  Following incubation, 10 µl of native gel loading buffer (120 mM Tris-HCl, pH 6.8, 161 
20% (v/v) glycerol, 0.005% (w/v) bromophenol blue, 1% (w/v) DTT) was added.  The proteins were 162 
electrophoresed on 15 %(w/v) polyacrylamide gels (buffer:  25 mM Tris, 160 mM glycine, pH 8.8) at 163 
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20 mA (constant current) for 4 h on ice, except for SmTAL10 (1.5 h) and SmTAL13 (3 h).  Proteins 164 
were visualised using Coomassie blue stain. 165 
 166 
Analytical methods 167 
Protein concentrations were determined by the method of Bradford using BSA as a standard [50].  168 
Differential scanning fluorimetry (DSF) was carried out as previously described [14, 29]. 169 
Protein-protein crosslinking was carried out using bis(sulfosuccinimidyl)suberate (BS3), a reagent 170 
which links exposed lysine residues [51].  SmTAL proteins (20 µM) were incubated in the presence of 171 
2 mM EGTA or 2 mM EGTA/4mM calcium chloride for 45 min at 37 °C.  BS3 (50-500 µM) was then 172 
added and the reaction allowed to proceed for 60 min at 37 °C before being terminated by the 173 
addition of SDS loading buffer (120 mM Tris-HCl, pH 6.8, 20% (v/v) glycerol, 0.005% (w/v) 174 
bromophenol blue, 1% (w/v) DTT, 4% (w/v) SDS) and heating to 95 °C for 3 min.  Reactions were 175 
analysed by SDS-PAGE. 176 
 177 
Results 178 
Cloning, expression and purification of SmTAL4-13 179 
In the case of SmTAL4-12, the DNA sequence amplified from S. mansoni cDNA was identical in 180 
sequence to those deposited in GenBank.  However, a sequence variation was detected in SmTAL13 181 
in which codon 26 (GAG encoding threonine) is substituted for GAA (alanine).  This sequence 182 
(submitted to GenBank with the accession number KX951466) was detected in several different 183 
amplicons, suggesting that it represents real variation in the genome rather than a PCR amplification 184 
error.  All ten SmTAL proteins could be expressed in, and purified from, E. coli cells with yields in the 185 
milligram per litre of bacterial culture range (Supplementary Figure S1).  The proteins were all 186 
released into the soluble fraction on sonication. 187 
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 188 
SmTAL proteins have different divalent ion binding properties 189 
The mobility of all 10 SmTAL proteins was measured in native gel electrophoresis (Figure 1).  A shift 190 
in the mobility of the protein in the presence of calcium ions compared to the absence of calcium 191 
(ensured by the addition of the specific calcium chelator EGTA) indicates a change in conformation 192 
resulting from ion binding.  The mobility SmTAL6, SmTAL7, SmTAL8 and SmTAL12 differed in the 193 
presence of calcium chloride suggesting that these proteins are able to bind the ion (Figure 1).  For 194 
all of these four proteins, the mobility of the untreated, recombinant protein was less than the EGTA 195 
treated protein (Figure 1).  This suggests that these proteins are purified largely in the calcium ion-196 
bound form.  Therefore, for all proteins, tests with other ions were carried in the presence of EGTA 197 
(to remove any bound calcium ions) and a molar excess of the ion.  The four proteins which were 198 
shown to bind calcium ions in this assay also bound to manganese ions (Figure 1).  SmTAL6 and 199 
SmTAL7 also bind to cadmium and nickel.  In addition, SmTAL6 interacted with lead ions (Figure 1).  200 
In these assays, no interaction with any of the ten proteins was detected with magnesium, iron (II) or 201 
potassium ions.  In a number of cases the presence of ion blurred the band in electrophoresis or 202 
even made it disappear entirely.  Examples include cadmium with SmTAL10, cobalt (II) with SmTAL4, 203 
SmTAL5, SmTAL6, SmTAL9, SmTAL10 and SmTAL11, copper (II) with SmTAL10, nickel with SmTAL4, 204 
SmTAL9, SmTAL10 and SmTAL11, zinc with SmTAL10 and lead with SmTAL4, SmTAL10 and SmTAL13.  205 
This is consistent with the ion causing denaturation of the protein so that it no longer runs as a 206 
discrete band.  In this assay, SmTAL4, SmTAL5, SmTAL9, SmTAL10, SmTAL11 and SmTAL13 were not 207 
shown to interact specifically with any ion. 208 
In differential scanning fluorimetry assays, all SmTAL proteins tested except SmTAL5 showed a 209 
statistically significant change in thermal stability (as reflected by the “melting temperature”, Tm) in 210 
the presence of calcium ions (Table 1).  The same proteins showed a change in thermal stability with 211 
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manganese ions.  Three of the proteins (SmTAL9, SmTAL10 and SmTAL11) also showed significant 212 
changes in the presence of magnesium ions (Table 1). 213 
 214 
Some SmTAL proteins bind to praziquantel and to calmodulin antagonists 215 
DSF was also used to detect interactions between SmTAL proteins and the calmodulin antagonists 216 
CPZ, W7, TFP and thiamylal.  Since there are previous reports showing that the antischistosomal 217 
drug PZQ interacts with the calmodulin-like protein myosin regulatory light chain and with SmTAL1, 218 
we also tested this drug [12, 34].  CPZ affected the Tm of SmTAL5, SmTAL9, SmTAL12 and SmTAL13 219 
(Table 2).  W7 affected just SmTAL9, SmTAL12 and SmTAL13, whereas TFP interacted with the 220 
majority of the proteins (i.e. SmTAL4, SmTAL5, SmTAL8, SmTAL9, SmTAL12 and SmTAL13).  PZQ 221 
interacted with SmTAL4, SmTAL5 and SmTAL8.  In the case of SmTAL6, SmTAL7, SmTAL10 and 222 
SmTAL11, no interaction was detected with any of the drugs used in these experiments. 223 
 224 
All the SmTAL proteins homodimerise 225 
In protein-protein crosslinking experiments, a new band corresponding to approximately twice the 226 
molecular mass of SmTALs was seen in all cases (Figure 2).  For some proteins (notably SmTAL9), this 227 
band was present even in the absence of crosslinker, suggesting a very high affinity interaction 228 
which was not completely dissociated under the conditions of SDS-PAGE.  This effect was also seen 229 
in some of the purification gels (Supplementary Figure S1) where, in general, the protein 230 
concentrations were higher.  In some cases, notably SmTAL10, higher molecular mass species were 231 
also detected following crosslinking (Figure 2).  It is, therefore, possible that some of the proteins 232 
exist in higher order oligomers or aggregates in addition to dimers. 233 
 234 
The SmTAL family proteins are predicted to have a broadly similar fold 235 
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Molecular modelling of the 10 SmTAL proteins revealed considerable similarities (Figure 3).  Each 236 
had a compact, N-terminal domain with two EF-hand structures present and a C-terminal DLC-like 237 
domain largely composed of β-sheet structures.  These two domains are joined by a linker, which is 238 
predicted to lack any defined secondary structure and is, most likely, quite flexible.  The mobility in 239 
this part of the proteins means that the two domains are likely to adopt a range of orientations with 240 
respect to each other.  There is also some variation in the length of the linker which is also likely to 241 
affect the relative orientations of the two globular domains.  The most extreme case of this is 242 
SmTAL8 which has a 31 residue linker resulting in considerable separation between the two domain 243 
(Figure 3).  In the case of SmTAL13 where our sequence differs from that previously reported, we 244 
made models corresponding to both sequences.  The N-terminal domains (residue 1-76) of these 245 
models align well with a root means square deviation (rmsd) of 0.826 Å over 995 equivalent atoms, 246 
as do the C-terminal domains (residues 106-176; rmsd of 1.307 Å over 878 equivalent atoms). 247 
Although the overall fold of the EF-hand domain is well conserved between the ten proteins, the 248 
sequence in the two EF-hands varies considerably.  A typical EF-hand provides six ligands from the 249 
protein to coordinate the ion, which are arranged approximately at right angles to each other.  250 
Consequently, they are known as the X, Y, Z, -X, -Y and –Z groups [52].  Detailed bioinformatics 251 
studies have identified the residues most commonly found at these positions.  Aspartate is favoured 252 
at X, Y, Z and –X although considerable variation is possible at –X.  At the –Z position, glutamate is 253 
favoured, although aspartate is used in a minority of cases.  The –Y position is unique among the six 254 
in that the backbone carbonyl, not side chain groups are used for coordination.  Threonine is the 255 
preferred residue at this positon, but a wide variety of alternative residues are possible.  Between 256 
the Z and –Y residues a glycine is almost always found to facilitate the tight turn which enables the 257 
EF-hand to wrap around the ion [52].  In previous work on FhCaBP2, the second EF-hand was shown 258 
to be the main site of interaction with calcium and manganese ions.  This EF-hand largely conforms 259 
to the consensus, with a lysine at position –Y [26]. 260 
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The first EF-hand deviates from the consensus in almost all of the 10 SmTAL proteins studied here.  261 
Only SmTAL10 and SmTAL13 have the central glycine residue required to create the tight turn in the 262 
middle of the motif.  In general, the lack of the glycine appears not to affect the fold of the EF-hand 263 
greatly.  This could result from the use of homology modelling which estimates structures by 264 
comparison to the closest available experimentally determined ones.  This might be expected to 265 
“force” residues into modelled structures which are not, in reality, favoured.  Examination of the 266 
Ramachandran plots for the first EF- hands for all ten proteins showed that, for SmTAL4, SmTAL6, 267 
SmTAL9, SmTAL10 and SmTAL13 all the residues were in the “favoured” regions of the plot.  For the 268 
remainder of the proteins, some residues (typically the residue on the turn or those adjacent to it) 269 
were in the “allowed” or “outlier” regions of the Ramachandran plot (data not shown).  This suggests 270 
that the EF-hand motif may be distorted from the ideal conformation in SmTAL5, SmTAL7, SmTAL8, 271 
SmTAL11 and SmTAL12. 272 
In general, the second EF-hands in the ten SmTAL proteins are closer to the consensus.  All but 273 
SmTAL6, SmTAL8 and SmTAL12 have the central, conserved glycine residue.  Only SmTAL4’s second 274 
EF-hand has a residue in the outlier region of the Ramachandran plot (Phe-55); SmTAL11 and 275 
SmTAL12 have one residue in the allowed region (Thr-50 and Lys-52 respectively).  All the remaining 276 
proteins’ second EF-hands have all the residues in the favoured region.  However, the residue at the 277 
–Z position only conforms to the consensus (Glu) in the case of SmTAL8 and SmTAL12, suggesting 278 
that these two proteins interact with calcium ions through the second EF-hand.  The other proteins 279 
have a range of residues which are all unable to provide oxygen atoms in their side chains for 280 
coordination of the ion.  While this may suggest that these EF-hands are unable to bind calcium, the 281 
experimental evidence presented here clearly demonstrates that the majority of these proteins do 282 
so.  Therefore, the ion must either bind elsewhere (most likely the first EF-hand) or the EF-hand 283 
must function differently to “classical” ones. 284 
 285 
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Bioinformatics analyses suggest functional groupings for this protein family 286 
To assist understanding of the different biochemical properties of these proteins we conducted a 287 
phylogenetic analysis of all 13 SmTAL proteins, together with known family members from other 288 
trematodes using calmodulins as an out-group.  Both maximum likelihood and neighbour-joining 289 
analyses gave similar results which revealed two clades (Figure 4).  One clade includes SmTAL1, 2, 8 290 
and 12.  It also includes all four F. hepatica CaBPs (and their F. gigantica homologues).  FhCaBP2 has 291 
been shown to interact with calcium primarily through its second EF-hand and sequence similarities 292 
at the EF-hands suggests that the same will be true for the other three F. hepatica CaBPs [14, 26].  In 293 
the four SmTAL proteins in this clade, the second EF-hand conforms to the consensus at the –Z 294 
position (Glu) suggesting that they also bind calcium at this site.  Typically these SmTAL proteins are 295 
also associated with larger changes in thermal stability, suggesting greater conformational change 296 
on binding (Table 1 and [34]).  This suggests a role for these proteins in calcium-mediated cellular 297 
signalling. 298 
The second clade includes all the remaining SmTAL proteins (SmTAL3, 4, 5, 6, 7, 9, 10, 11, 13) 299 
alongside similar proteins from other trematodes (Figure 4).  Four of these proteins (SmTAL7, 9, 10, 300 
13) lack the critical glutamate in their second EF-hand sequences and are likely to bind divalent ions 301 
mainly at the first EF-hand.  This conclusion is supported by the presence of the C. sinensis protein 302 
CsTAL3 (Cs20.8) in this clade.  X-ray crystallographic studies have clearly demonstrated that this 303 
protein interacts through the first EF-hand [53]. However the biochemical properties of SmTAL 304 
proteins from this clade are diverse.  Thus, this group may contain proteins with a mainly structural 305 
role and those which are involved in calcium signalling using the first EF-hand. 306 
The remaining proteins (SmTAL3, 4, 5, 6 and 11) include proteins with no detectable divalent ion 307 
binding activity (SmTAL3 and SmTAL5) with some which have been shown to bind ions (SmTAL4, 6 308 
and 11) (Figure 1, Table 1, Table 3 [34]).  SmTAL3 has been shown to form part of a high molecular 309 
mass complex [22].  This protein, and also SmTAL5, readily form higher order oligomers in 310 
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crosslinking experiments (Figure 2).  This suggests that at least some of these proteins may have 311 
structural, rather than signalling, roles. 312 
 313 
Discussion 314 
Despite similarity in sequences and predicted domain organisation there is known to be 315 
considerable variation in the biochemical properties of this protein family [14].  Therefore, it was not 316 
surprising to discover diversity in this group of ten SmTAL proteins.  The results from binding 317 
experiments described in this paper and our previous work are summarised in Table 3 [34].  Native 318 
gel electrophoresis demonstrated different ion binding properties for the ten proteins.  In this assay 319 
calcium ion binding was not detected for six of the proteins.  However, it should be noted that this 320 
assay will only detect ion binding where the interaction is long-lived under the conditions of the 321 
experiment and results in a conformational change which alters the electrophoretic mobility of the 322 
protein.  Therefore, while the presence of a shift is strong evidence of ion binding, the absence of a 323 
shift does not necessarily indicate that there is no affinity for that ion.  In DSF, calcium binding was 324 
detected for all of the proteins, except SmTAL5.  Therefore, we conclude that SmTAL5, like SmTAL3, 325 
has no significant calcium binding activity [34]. 326 
The location of the calcium binding site(s) in the remaining SmTAL proteins is not always clear.  327 
While the known members of the FhCaBP family appear to bind divalent ions primarily through the 328 
second EF-hand, this seems unlikely to be the case for all SmTAL proteins.  Based on our structural 329 
predictions and bioinformatics analyses, we hypothesise that SmTAL1, 2, 8 and 12 all interact 330 
through the second EF-hand.  These four proteins are grouped in the same clade as the FhCaBP 331 
family and, except for SmTAL8, have a second EF-hand that conforms well to the consensus 332 
sequence.  SmTAL10 and 13 are likely to bind through the first EF-hand.  For these two proteins, the 333 
second EF-hand lacks the glycine residue required for the tight turn, but this residue is present in the 334 
first EF-hand.  They also both appear in the second clade in our bioinformatics analysis.  It is 335 
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tempting to extend this argument to the other two SmTAL proteins in this clade (SmTAL7 and 9).  336 
While the F. hepatica proteins FhCaBP1, FhCaBP2, FhCaBP3 and FhCaBP4 all appear to interact 337 
primarily through the second EF-hand, there is experimental evidence for members of this protein 338 
family interacting through the first EF-hand [23, 25, 26, 29].  The crystal structure of the EF-hand 339 
domain from the C. sinensis protein, CsTAL3 has been solved and clearly demonstrates that this 340 
protein interacts through the first EF-hand [53].  X-ray scattering data on the full-length protein in 341 
solution suggested that it undergoes conformational changes on binding to calcium ions, becoming 342 
more extended in response to ion binding.  This suggests that binding at the first EF-hand can also 343 
elicit the kind of conformational changes involved in signalling [53].  The situation remaining SmTAL 344 
proteins for which there is evidence of calcium binding (SmTAL4, 6 and 11) is less clear.  These 345 
protein sequences were not clearly grouped in our bioinformatics analysis.  Further experimental 346 
work will be required to confirm the locations of divalent cation binding sites in the SmTAL protein 347 
family. 348 
It is reasonable to assume that all 13 TAL proteins arose from a single ancestral protein which almost 349 
certainly bound calcium ions.  If this is the case, then SmTAL3 and SmTAL5 have lost the ability to 350 
bind calcium through evolution.  This suggests that, while the majority of SmTAL proteins reversibly 351 
interact with calcium ions in a functionally important way, there are calcium-independent functions 352 
of some family members.  Other than a single report that SmTAL3 forms part of a larger complex 353 
which includes dynein components, no functional information is available for the SmTAL family [22].  354 
The requirement for 13 different family members is also an unresolved mystery.  We hypothesise 355 
that the majority of the proteins function in calcium signalling processes and that their functions are 356 
likely to partially overlap.  The two non-calcium binding SmTAL proteins most likely function as 357 
structural components of larger complexes.  Given the parasite’s requirement to live in two hosts (a 358 
warm-blooded mammal and a cold-blooded snail) as well in several free living forms, it is possible 359 
that different family members fulfill similar role(s) but in different life cycle stages.  Consistent with 360 
this hypothesis, mRNA coding for the 13 SmTAL proteins show different expression profiles [16].  361 
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While some of the mRNA molecules are expressed in all life cycle stages (e.g. SmTAL2, 7, 8 and 12), 362 
others are only produced early or late in the cycle.  SmTAL6 mRNA is produced only in eggs, 363 
miracidia and sporocysts.  In contrast, SmTAL3 and 11 mRNA are mainly produced in adult worms 364 
[16].  Of course, mRNA expression does not always correlate perfectly with the presence of the 365 
corresponding proteins.  Some proteins can have long half-lives and persist after the corresponding 366 
mRNA is degraded.  Indeed some human calcium binding proteins can persist in cells for days or 367 
weeks [54, 55].  Nevertheless, these differences in mRNA expression strongly suggest that the levels 368 
of each SmTAL protein will vary across the life-cycle.  We did not observe any obvious correlation 369 
between the thermal stability of the proteins and their life cycle stage – for example SmTAL6 (whose 370 
mRNA is produced in the eggs) has the highest melting temperature in the DSF assay. 371 
Although we have been able to make some broad functional predictions about these proteins based 372 
on sequence analysis and our biochemical data, further experiments will be required to elucidate 373 
their roles.  Based on our drug-binding experiments, it seems unlikely that it will be possible to 374 
identify compounds which selectively antagonise one family member.  Therefore, genetic methods 375 
are more likely to be successful in obtaining worms which lack a functional form of one family 376 
member.  RNAi methods are now well-established in S. mansoni although some caution would be 377 
required since the proteins may have long half-lives (see above) [56].  CRISPR/Cas9 gene editing 378 
techniques may also become established for Schistosoma spp and some enabling technologies have 379 
already been reported [57].  These methods may enable the selective knock-down or knock out of 380 
the individual family members and studies on the resulting phenotype to be undertaken.  Classical 381 
biochemical techniques may also be useful.  Affinity chromatography or pull-down experiments 382 
could be used to identify protein binding partners within cell extracts.  The most commonly used 383 
forms of these assays tend to identify mainly soluble proteins.  Given the SmTAL proteins’ likely role 384 
in calcium signalling, it is possible that they interact with membrane bound or associated proteins 385 
(e.g. subunits of the voltage-gated calcium channels).  Therefore, methods which enable the capture 386 
and identification of membrane proteins should also be used [58].  Such studies will be potentially 387 
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valuable since they will permit the inference of functional roles for the SmTAL family members and 388 
may provide some clues into their different roles within the parasite. 389 
The tantalising finding that praziquantel interacts with SmTAL1, 4, 5 and 8 suggests that these 390 
proteins may be pharmacologically important.  This further suggests that novel drugs might be 391 
designed to antagonise the functions of family members.  The protein kinase inhibitor, staurosporine 392 
has been identified by in silico methods as a likely binding partner for C. sinensis protein CsTegu20.6.  393 
This protein is a member of the same protein family as the SmTAL proteins [33].  Although this has 394 
not been tested experimentally, it does suggest that there are druggable pockets in these proteins 395 
which could be exploited in drug discovery.  Overall, the work to date on this protein family suggests 396 
that they perform diverse roles are various life cycle stages in trematodes.  Further elucidation of 397 
these roles is likely to increase our understanding of the basic biochemistry of these organisms and 398 
may pave the way to novel treatments for the infections they cause. 399 
 400 
Acknowledgements 401 
We thank Prof Aaron Maule (Queen’s University, Belfast) for access to a qPCR machine used for DSF 402 
assays.  CMT was funded by a PHD studentship from the Department of Employment and Learning, 403 
Northern Ireland (DELNI, UK).  GT was supported by the Ministry of Education (MEC) and the 404 
Ministry of Science and Technology (MCT), Brazil. 405 
  406 
18 
 
Figure legends 407 
Figure 1:  Ion binding of SmTAL proteins.  Native gel electrophoresis (for conditions, see Materials 408 
and Methods) was used to assess binding to a range of divalent metal cations.  A discrete shift in 409 
electrophoretic mobility (marked with an asterisk, *) indicates interaction with the ion. 410 
Figure 2:  Homodimerisation of SmTAL proteins.  Protein-protein crosslinking was used to assess the 411 
ability of the SmTALs to dimerise.  The appearance of additional band (**) at approximately twice 412 
the molecular mass of the native protein (*) indicates dimerization.  In some cases (notably SmTAL5, 413 
10 and 11) additional bands at higher molecular masses were detected suggesting oligomerisation or 414 
aggregation of these proteins also occurs.  Note that SmTAL9 has a detectable amount of dimer 415 
present even in the absence of crosslinking agent.  In each gel:  M, molecular mass markers (116, 66, 416 
45, 35, 25, 18, 14 kDa); U, untreated protein (20 µM); numbers, protein treated with the 417 
corresponding concentration (in µM) of BS3.  EGTA indicates experiments done in 2 mM EGTA; Ca2+, 418 
experiments done in 2 mM EGTA/4 mM calcium chloride.  For other experimental conditions, see 419 
Materials and Methods. 420 
Figure 3:  Predicted EF-hand structures from SmTALs.  The overall fold of the SmTAL proteins was 421 
predicted by molecular modelling (see Materials and Methods).  In each case, the EF-hand domain is 422 
shown on the left and the DLC-like domain on the right.  Calcium ions are shown in the first or 423 
second EF-hand according to the predictions made in this paper.  Where no calcium ion binding is 424 
predicted, or the position of the ion is uncertain, the structure is shown with no ions bound. 425 
Figure 4:  Protein sequence analysis of the SmTAL family and related proteins.  (a) Maximum 426 
likelihood and (b) neighbour-joining analyses were conducted as described in the Methods.  427 
Calmodulin (CaM) sequences were used as an outgroup.  This figure displays the bootstrap 428 
consensus trees (1000 replicates).  The trees are drawn to scale, with branch lengths in the same 429 
units as those of the evolutionary distances used to infer the phylogenetic tree.   Accession codes:  430 
FhCaBP1 (AML33332); FhCaBP2 (AJF23779); FhCaBP3 (AFX60920); FhCaBP4 (AFM84632); FgCaBP1 431 
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(AAZ20312); FgCaBP3 (AEX92828); FgCaBP4 (AEX92829); Cs GAA37705 (GAA37705); Cs GAA47752 432 
(GAA47752); Cs GAA56892 (GAA56892); Cs20.8 (ABC47326): Cs21.6 (AEI69651); Cs21.7 (GAA49984); 433 
Cs22.3 (ABK60085); OvT265 08981 (XP_009173195); OvT265 10763 (XP_009175494); Sh21.7 434 
(XP_012797374); Sh22.6 (BAF62289); Sh_teg_ant (SmTAL3) (XP_012797371); Sh_teg_ant (SmTAL8) 435 
(XP_012797375); Sh_teg_ant (SmTAL11) (XP_012797369); ShTAL4 (XP_012797370); ShTAL5 436 
(XP_012797368); ShTAL9 (XP_012797728); ShTAL12 (XP_012799748); ShTAL13 (XP_012795330); 437 
ShMS3 03822 (XP_012795331); ShMS3 04275 (XP_012795756); Sj20 (AAP06272); Sj22.6 438 
(AAB52407); Sj_teg_ant (CAX72713); Sj_EF_prot (CAX73132); SjTAL9 (CAX73272); SJCHGC00558 439 
(AAW26845); SJCHGC01853 (AAW25529); SJCHGC06339 (AAP06136); SJCHGC08815 (AAX27568); 440 
SJSCG09029 (AAW26125); SmCaM1 (ADW78835), SmCaM2 (ADW78836); FhCaM (CAL91032); 441 
EmCaM (CDS37648); HmCaM (CDS28106); DjCaM (BAD88634); HsCaM (AAD45181). 442 
  443 
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Table 1:  Thermal stability (Tm in °C) of SmTAL proteins in the presence and absence of selected 
divalent metal ions. 
Protein Untreated EGTA CaCl2 MnCl2 MgCl2 
SmTAL4 59.1± 0.2ns 58.7± 0.2 60.3± 0.4**** 60.4± 0.1**** 58.9± 0.1ns 
SmTAL5 47.6± 0.1ns 47.9± 0.1 47.7± 0.4ns 47.8± 0.2ns 48.0± 0.3ns 
SmTAL6 73.9± 0.4ns 74.1± 0.1 76.5± 0.3**** 68.6± 0.1**** 74.1± 0.3ns 
SmTAL7 64.8± 0.3* 63.9± 0.4 69.5± 0.3**** 67.6± 0.1**** 64.6± 0.3ns 
SmTAL8 58.7± 0.2**** 61.4± 0.4 59.3± 0.3*** 60.0± 0.7** 61.2± 0.3ns 
SmTAL9  68.6± 0.1ns 68.8± 0.2 59.5± 0.0**** 53.6± 0.2**** 62.5± 0.0**** 
SmTAL10 67.6± 0.5**** 64.5± 0.3 72.0± 0.2**** 73.8± 0.3**** 74.5± 0.0**** 
SmTAL11 49.8± 0.4**** 47.2± 0.4 49.5± 0.0**** 49.4± 0.1**** 50.1± 0.1**** 
SmTAL12 69.7± 0.5** 66.8± 0.2 71.5± 0.2**** 71.4± 0.1**** 63.1± 1.4ns 
SmTAL13 63.2± 0.1ns 63.2± 0.2 62.3± 0.3*** 60.6± 0.2**** 63.1± 0.1ns 
 
In all cases, the protein concentration was 10 µM buffered by Hepes-OH (20 mM; pH 7.4).  Where 
present, EGTA was 1 mM.  Ions were present at 2 mM with 1 mM EGTA.  Significance was 
determined versus EGTA treatment group using ANOVA (n = 3; significance threshold of p ⩽ 0.05) 
and Tukey’s post-hoc test (mean of each group tested against the mean of every other group).  ns, 
not significant; * P ⩽ 0.05; ** P ⩽ 0.01; *** P ⩽ 0.001; ****P ⩽ 0·0001. 
Table 1
Table 2:  Thermal stability (Tm in °C) of SmTAL proteins in the presence and absence of selected drugs. 
Protein Untreated 
(+Calcium) 
DMSO PZQ CPZ W7 TFP ThA 
SmTAL4 60.7± 0.2ns 60.7± 0.3 60.1± 0.1** 60.3± 0.2ns 60.5± 0.0ns 60.2± 0.2* 60.6± 0.1ns 
SmTAL5 47.5± 0.2ns 47.7± 0.3 46.4± 0.7* 45.8± 0.3*** 47.8± 0.3ns 44.4± 0.4**** 47.3± 0.4ns 
SmTAL6 76.7± 0.2ns 76.4± 0.2 76.3± 0.2ns 76.2± 0.2ns 76.2± 0.2ns 76.4± 0.1ns 76.1± 0.1ns 
SmTAL7 69.6± 0.4ns 69.5± 0.2 69.3± 0.2ns 69.2± 0.0ns 69.1± 0.3ns 68.9± 0.2ns 69.4± 0.3ns 
SmTAL8 58.8± 0.4ns 58.6± 0.4 56.6± 0.1**** 58.7± 0.4ns 58.4± 0.2ns 57.2± 0.3*** 58.6± 0.2ns 
SmTAL9 59.5± 0.0ns 59.8± 0.1 59.9± 0.1ns 59.2± 0.2*** 58.9± 0.1**** 58.9± 0.1**** 59.9± 0.1ns 
SmTAL10 72.1± 0.4ns 71.6± 0.9 71.7± 0.3ns 71.6± 0.1ns 71.7± 0.3ns 71.3± 0.4ns 71.5± 0.9ns 
SmTAL11 49.3± 0.3ns 49.2± 0.3 49.1± 0.1ns 49.4± 0.2ns 49.6± 0.2ns 49.1± 0.1ns 49.3± 0.2ns 
SmTAL12 71.4± 0.1ns 71.1± 0.1 70.8± 0.2ns 70.5± 0.0*** 70.6± 0.1** 69.8± 0.2**** 70.9± 0.1ns 
SmTAL13 62.4± 0.1ns 62.3± 0.2 61.8± 0.4ns 60.6± 0.2**** 61.1± 0.1**** 60.4± 0.1**** 62.2± 0.1ns 
 
SmTAL proteins were present at 10 µM in the presence of EGTA (1 mM)/calcium chloride (2 mM) and buffered by Hepes-OH (20 mM; pH 7.4).  All drugs 
were present at a concentration of 250 µM with DMSO at 1%(v/v).  Significance was determined by comparison to the DMSO treated group using ANOVA (n 
= 3; significance threshold of p ⩽0.05) and Tukey’s post-hoc test (mean of each group tested against the mean of every other group).  ns, not significant; * P 
⩽ 0.05; ** P ⩽ 0.01; *** P ⩽ 0.001; ****P ⩽ 0·0001.  PZQ, praziquantel; CPZ, chlorpromazine; W7, N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide; 
TFP, trifluoperazine; ThA, thiamylal.   
Table 2
Table 3:  Summary of experimental results from binding experiments. 
Protein Ions bound (native 
gels) 
Ions bound 
(DSF)2 
Drugs bound 
(DSF) 
Phylogenetic 
grouping 
 
SmTAL11 Ca2+, Mn2+, Ni2+, Sr2+ Ca2+ PZQ, CPZ, W7, TFP   
SmTAL21 Ca2+, Mn2+, Mg2+ nd nd   
SmTAL31 None None CPZ, W7, TFP   
SmTAL4 None Ca2+, Mn2+ PZQ, TFP   
SmTAL5 None None PZQ, CPZ, TFP   
SmTAL6 Ca2+, Mn2+, Ni2+, Pb2+ Ca2+, Mn2+ None   
SmTAL7 Ca2+, Mn2+, Ni2+ Ca2+, Mn2+ None   
SmTAL8 Ca2+, Mn2+ Ca2+, Mn2+ PZQ, TFP   
SmTAL9  None Ca2+, Mn2+, Mg2+ CPZ, W7, TFP   
SmTAL10 None Ca2+, Mn2+, Mg2+ None   
SmTAL11 None Ca2+, Mn2+, Mg2+ None   
SmTAL12 Ca2+, Mn2+ Ca2+, Mn2+ CPZ, W7, TFP   
SmTAL13 None Ca2+, Mn2+ CPZ, W7, TFP   
 
1 Data from previous work of Thomas et al.  Note that this study considered a slightly smaller range of ions in the native gel and DSF experiments.  It was not 
possible to determine a Tm value for SmTAL2 and so ion or drug binding by DSF were not determined (nd). 
2 Only calcium (SmTAL1-3) or calcium, magnesium and manganese (SmTAL4-13) ions were considered in this experiment 
None means “none of those ions or drugs tested”. 
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